ACTRN12617000166370
Completed
N/A
Efficacy of early referral to palliative care for improving quality of life and health care resources following recent diagnosis of advanced thoracic maglignancies.
ConditionsAdults with advanced thoracic malignancy (NSCLC, SCLC orMPM) that have been newly diagnosed within the last 60 days.Adults with advanced thoracic malignancy (NSCLC, SCLC orMPM) that have been newly diagnosed within the last 60 days.Cancer - Lung - Small cellCancer - Lung - Non small cellCancer - Lung - Mesothelioma
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Adults with advanced thoracic malignancy (NSCLC, SCLC orMPM) that have been newly diagnosed within the last 60 days.
- Sponsor
- niversity of Sydney
- Enrollment
- 113
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Adults, aged 18 years and older, with a histological or cytological diagnosis within the last 60 days of either:
- •(a)Advanced NSCLC (this includes de novo stage IV disease, recurrent NSCLC after definitive treatment, and locally advanced disease which is not planned for curative resection). Patients planned to receive curative intent chemoradiation for locally advanced disease are eligible or
- •(b)Advanced SCLC (this includes extensive stage SCLC, recurrent SCLC after definitive treatment and locally advanced disease), or
- •(c)Advanced MPM which is not planned for extrapleural pneumonectomy or pleurectomy\-decortication.
- •2\.Australia\-modified Karnofsky performance status of 50 to 100 at the time of randomisation (see Appendix 1\).
- •3\.Willing and able to comply with all study requirements, including ability at the time of screening to complete the QOL questionnaires without assistance, in accordance with protocol requirements.
- •4\. Signed, written informed consent.
Exclusion Criteria
- •1\. Immediate referral to palliative care required, or already referred to palliative care (this
- •includes referral to a community or hospital based palliative care service, or palliative care
- •physician).
- •2\. Life expectancy of less than 3 months.
- •3\. Serious medical or psychiatric onditions that might limit the ability of the patient to comply with the protocol.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
The effect of early palliative care on quality of life and self-care behaviours in patient with type2 diabetesIRCT20231107059976N1Tehran University of Medical Sciences100
Completed
N/A
Early Palliative Care for patients with symptomatic Heart FailureI50.12I50.13I50.14DRKS00013922niklinik BonnMedizinische Klinik II206
Not Yet Recruiting
Phase 2
A clinical trial to study the effect of starting early palliative care with chemotherapy at diagnosis of advanced sarcoma compared to chemotherapy alone.CTRI/2019/05/019367VIKAS GARG
Completed
Phase 1
Early specialty palliative care for patients with advanced lung cancer undergoing chemotherapy: Feasbility studyAdvanced Lung CancerJPRN-UMIN000012772ational Cancer Center Hospital East50
Completed
N/A
Early Palliative Care – Health services research and implementation of sustainable changesC34center-specific tumor entitiesC15C16C25Malignant neoplasm of bronchus and lungMalignant neoplasm of oesophagusMalignant neoplasm of stomachMalignant neoplasm of pancreasDRKS00006162Klinik für Pallliativmedizin, Universitätsklinikum Freiburg592